JPRN-UMIN000031733已完成未知
Efficacy and safety of phosphate binders in patients on hemodialysis - Phosphate binders in patients on HD
ihon University School of Medicine0 个研究点目标入组 60 人开始时间: 2018年3月14日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) a history of severe heart failure, angina, myocardial infarction, or stroke within the past 6 months; (2) the presence of infectious disease, malignant tumors, or treatment with steroids or immunosuppressants; (3) current hospitalization
研究者
相似试验
已完成
不适用
Efficacy and safety of phosphate binders, ferric citrete hydrate and lanthunam carbohydrate, in patients undergoing maintenance hemodialysisJPRN-UMIN000021818Divisions of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine60
已完成
2 期
Therapeutic Equivalence of OsvaRen® Tablets and OsvaRen® GranulesChronic Kidney DiseaseHyperphosphatemiaNCT02027662Fresenius Medical Care Deutschland GmbH61
已完成
不适用
Safety and efficacy of polyphosphate for the treatment of ulcerative colitis(AMU002-CR01)JPRN-UMIN000021555Asahikawa Medical University10
尚未招募
不适用
Patient preference based phosphate binder therapyNL-OMON25073Amsterdam UMC, location VUmc40
进行中（未招募）
1 期
Feasibility of an approach in which treatment of high phosphate levels with phosphate binders in dialysis patients is based on preferences of the patient.EUCTR2019-003698-24-NLAmsterdam UMC, location VUmc40